Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population
Clinical trial NCT05480436 · UNKNOWN
Trial details
- NCT number
- NCT05480436
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2023-01-30
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.